liver-cancer

Documents about liver-cancer

• On-treatment Biomarkers in Metastatic Colorectal Cancer for Life#839303ClinicalTrials.gov
• A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer#855419ClinicalTrials.gov
• Hepatic Arterial Infusion (HAI) of Abraxane#993003ClinicalTrials.gov
• Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas#892974ClinicalTrials.gov
• Postoperative Exercise Training in Patients With Colorectal Liver Metastases Undergoing Surgery (ELMA)#886585ClinicalTrials.gov
• The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases#907881ClinicalTrials.gov
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)#841847ClinicalTrials.gov
• A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors#405118ClinicalTrials.gov
• Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma#807489ClinicalTrials.gov
• Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients#867723ClinicalTrials.gov
• Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer#1010139ClinicalTrials.gov
• A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer#143559ClinicalTrials.gov
• FedLiverNet: a federated learning framework for privacy-preserving and efficient liver cancer detection.#251115NCBI PubMed Central
• Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)#256885ClinicalTrials.gov
• Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic#285517PubMed Central
• Liver cancer in Japan: epidemiological transition, viral hepatitis control, and emerging challenges.#653541NCBI PubMed Central
• Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function#811423ClinicalTrials.gov
• Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors Ablation#865827ClinicalTrials.gov
• MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism#872739ClinicalTrials.gov
• HepATocellular Cancer Hcv Therapy Study#873201ClinicalTrials.gov
• Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer#971151HAL (France)
• Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls#634702eScholarship
• Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer#1045943ClinicalTrials.gov
• VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer#460079ClinicalTrials.gov
• Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery#873279ClinicalTrials.gov
• Randomized Control Trial (RCT) of Early Palliative Care for HCC#828328ClinicalTrials.gov
• Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)#833700ClinicalTrials.gov
• Folfox-B Study for Patients With Colorectal Liver Metastases#848755ClinicalTrials.gov
• Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program#900360ClinicalTrials.gov
• DNP-MRSI of HCC Metabolism to Predict Therapeutic Response#812606ClinicalTrials.gov
• Clinical Significance of Hepatic Biomarkers in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors#873179ClinicalTrials.gov
• Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer#992878ClinicalTrials.gov
• Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)#848711ClinicalTrials.gov
• Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC#67884ClinicalTrials.gov
• High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM#230400ClinicalTrials.gov
• Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCC#454011ClinicalTrials.gov
• Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma#454030ClinicalTrials.gov
• Interventional X-ray and Scintigraphy Imaging of 99mTc-MAA During the Radioembolisation Pretreatment Procedure#833971ClinicalTrials.gov
• Defining the Ablative Dose for Y-90 TARE#834324ClinicalTrials.gov
• DKN-01 Inhibition in Advanced Liver Cancer#840995ClinicalTrials.gov
• Cytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic Correlation#865017ClinicalTrials.gov
• A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma#995514ClinicalTrials.gov
• The Development of MASLD Among Survivors of Breast or Colorectal Cancer#343833ClinicalTrials.gov
• A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis#329533ClinicalTrials.gov
• Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer#804920ClinicalTrials.gov
• Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology#807343ClinicalTrials.gov
• Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study#1008410ClinicalTrials.gov
• Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors#1007738ClinicalTrials.gov
• Laryngeal mask airway use during liver transplantation: perioperative outcomes in a propensity score-matched cohort#614833Figshare
• A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases#862850ClinicalTrials.gov